Donald Trump signed an executive order that could reclassify marijuana from Schedule I to Schedule III, following months of internal planning and an earlier Oval Office announcement that he would reschedule the drug.The order directs agencies including the DEA to speed formal rule making, expands access to CBD through a Medicare reimbursement pilot and asks HHS to use real‑world evidence to study long‑term effects, though the timeline for rule making remains unclear.More than twenty Republican senators led by Ted Budd opposed the move and critics warned it will not legalize recreational use or immediately change prosecutions, while industry figures such as Vince C. Ning and Paul Armentano welcomed steps to boost research and ease tax and banking barriers.